These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 12360279)

  • 21. AID and RAG1 do not contribute to lymphomagenesis in Emu c-myc transgenic mice.
    Nepal RM; Zaheen A; Basit W; Li L; Berger SA; Martin A
    Oncogene; 2008 Aug; 27(34):4752-6. PubMed ID: 18408759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brief inactivation of c-Myc is not sufficient for sustained regression of c-Myc-induced tumours of pancreatic islets and skin epidermis.
    Pelengaris S; Abouna S; Cheung L; Ifandi V; Zervou S; Khan M
    BMC Biol; 2004 Dec; 2():26. PubMed ID: 15613240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B-myc: N-terminal recognition of myc binding proteins.
    Burton RA; Mattila S; Taparowsky EJ; Post CB
    Biochemistry; 2006 Aug; 45(32):9857-65. PubMed ID: 16893186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic binding and transcriptional regulation by the Drosophila Myc and Mnt transcription factors.
    Orian A; Grewal SS; Knoepfler PS; Edgar BA; Parkhurst SM; Eisenman RN
    Cold Spring Harb Symp Quant Biol; 2005; 70():299-307. PubMed ID: 16869766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
    Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
    Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth.
    Pelengaris S; Khan M
    Expert Opin Ther Targets; 2003 Oct; 7(5):623-42. PubMed ID: 14498825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disentangling the MYC web.
    Levens D
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):5757-9. PubMed ID: 11983876
    [No Abstract]   [Full Text] [Related]  

  • 28. [File no.47: CMYC].
    Soussi T
    Bull Cancer; 2001 Nov; 88(11):1053-4. PubMed ID: 11741797
    [No Abstract]   [Full Text] [Related]  

  • 29. The Myc world within reach.
    Sodir NM; Soucek L
    Methods Mol Biol; 2013; 1012():1-6. PubMed ID: 24006054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of interleukin-6 in the pathogenesis of murine plasmacytoma and human multiple myeloma.
    Pattengale PK
    Am J Pathol; 1997 Sep; 151(3):647-9. PubMed ID: 9284811
    [No Abstract]   [Full Text] [Related]  

  • 31. Ratcheting Myc.
    Freie BW; Eisenman RN
    Cancer Cell; 2008 Dec; 14(6):425-6. PubMed ID: 19061831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The myc oncogene: MarvelouslY Complex.
    Oster SK; Ho CS; Soucie EL; Penn LZ
    Adv Cancer Res; 2002; 84():81-154. PubMed ID: 11885563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myc and Myb: are the veils beginning to lift?
    Prendergast GC
    Oncogene; 1999 May; 18(19):2914-5. PubMed ID: 10378687
    [No Abstract]   [Full Text] [Related]  

  • 34. Transcriptional activation by the Myc oncoprotein.
    Cole MD; Nikiforov MA
    Curr Top Microbiol Immunol; 2006; 302():33-50. PubMed ID: 16620024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mast cells and pancreatic cancer.
    Theoharides TC
    N Engl J Med; 2008 Apr; 358(17):1860-1. PubMed ID: 18434656
    [No Abstract]   [Full Text] [Related]  

  • 36. Conditional transgenic models define how MYC initiates and maintains tumorigenesis.
    Arvanitis C; Felsher DW
    Semin Cancer Biol; 2006 Aug; 16(4):313-7. PubMed ID: 16935001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ever expanding role for c-Myc in promoting genomic instability.
    Prochownik EV; Li Y
    Cell Cycle; 2007 May; 6(9):1024-9. PubMed ID: 17426456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. c-Myc, Genomic Instability and Disease.
    Kuttler F; Mai S
    Genome Dyn; 2006; 1():171-190. PubMed ID: 18724060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MYC-y mice: from tumour initiation to therapeutic targeting of endogenous MYC.
    Morton JP; Sansom OJ
    Mol Oncol; 2013 Apr; 7(2):248-58. PubMed ID: 23523308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. c-Myc: where death and division collide.
    Brunner T; Martin SJ
    Cell Cycle; 2004 Apr; 3(4):456-9. PubMed ID: 14963405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.